Literature DB >> 28236320

Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients.

Xu Jiang1,2, Qian Zhang1, Hua-Bin Wang3, Xiao-Fan Cui2, Rui Liu2.   

Abstract

OBJECTIVES: To evaluate the associations of urinary markers (eg albumin), glomerular (eg transferrin [TRF], immunoglobulin G [IgG]), and tubular (eg α1-microglobulin [α1-MG], β2-microglobulin [β2-MG]) markers with the development of diabetic kidney disease (DKD) in type 2 diabetes patients, as assessed by estimated glomerular filtration rate (eGFR) and albuminuria.
MATERIAL AND METHODS: A total of 252 type 2 diabetes patients and 50 nondiabetic controls from Tianjin, China, were selected. Diabetic patients were divided into three groups according to eGFR levels, including groups A, B, and C with eGFR ≥90 (n=94), 60-89 (n=94), and 30-59 (n=64) mL/min/1.73 m2 . Urine levels of glomerular and tubular markers were detected in first morning urine samples, and their associations with eGFR and albuminuria analyzed.
RESULTS: Urinary levels of IgG, TRF, and β2-MG were significantly elevated in diabetic patients with normal eGFR compared with nondiabetic control subjects. Urinary levels of all markers increased per eGFR stratum. All kidney damage markers were significantly associated with eGFR in univariate analysis (standard β between -0.35 and -0.28; all P<.001). After adjusting for known confounders, only the tubular markers α1-MG (standard β=-0.25; P=.013) and β2-MG (standard β=-0.18; P=.039) retained significant associations with eGFR. All kidney damage markers were significantly associated with albuminuria, independent of age, duration of diabetes, and eGFR (standard β between 0.45 and 0.86; all P<.001).
CONCLUSION: Only the tubular markers α1 -MG and β2 -MG were associated with eGFR independent of albuminuria, suggesting that they may play an important role in the development of DKD.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  albuminuria; diabetic kidney disease; glomerular filtration rate; α1-microglobulin; β2-microglobulin

Mesh:

Substances:

Year:  2017        PMID: 28236320      PMCID: PMC6817283          DOI: 10.1002/jcla.22191

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  22 in total

Review 1.  Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.

Authors:  George Jerums; Sianna Panagiotopoulos; Erosha Premaratne; David A Power; Richard J MacIsaac
Journal:  Am J Nephrol       Date:  2008-02-19       Impact factor: 3.754

2.  Extended prognostic value of urinary albumin excretion for cardiovascular events.

Authors:  Auke H Brantsma; Stephan J L Bakker; Dick de Zeeuw; Paul E de Jong; Ronald T Gansevoort
Journal:  J Am Soc Nephrol       Date:  2008-06-04       Impact factor: 10.121

3.  Pioglitazone delays proximal tubule dysfunction and improves cerebral vessel endothelial dysfunction in normoalbuminuric people with type 2 diabetes mellitus.

Authors:  Ligia Petrica; A Vlad; M Petrica; C D Jianu; Gh Gluhovschi; Florica Gadalean; V Dumitrascu; Calina Ianculescu; Catalina Firescu; S Giju; Cristina Gluhovschi; F Bob; Silvia Velciov; Gh Bozdog; Oana Milas; Roxana Marian; S Ursoniu
Journal:  Diabetes Res Clin Pract       Date:  2011-07-02       Impact factor: 5.602

4.  Alpha-1 microglobulin: a marker for early detection of tubular disorders in diabetic nephropathy.

Authors:  Najla Shore; Rukhshan Khurshid; Mahjabeen Saleem
Journal:  J Ayub Med Coll Abbottabad       Date:  2010 Oct-Dec

Review 5.  Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression.

Authors:  Elise Schutte; Ron T Gansevoort; Jacqueline Benner; Helen L Lutgers; Hiddo J Lambers Heerspink
Journal:  Nephrol Dial Transplant       Date:  2015-08       Impact factor: 5.992

6.  Glomerular and tubular damage markers in individuals with progressive albuminuria.

Authors:  Ferdau L Nauta; Lieneke Scheven; Esther Meijer; Wim van Oeveren; Paul E de Jong; Stephan J L Bakker; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

Review 7.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

8.  Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore.

Authors:  Ching-Ye Hong; Kenneth Hughes; Kee-Seng Chia; Vivian Ng; Sing-Lin Ling
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

Review 9.  Early nephropathy in type 1 diabetes: the importance of early renal function decline.

Authors:  Bruce A Perkins; Andrzej S Krolewski
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

10.  Comment on: American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care 2011;34(Suppl. 1):S11-S61.

Authors:  Vittorio Basevi; Simona Di Mario; Cristina Morciano; Francesco Nonino; Nicola Magrini
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

View more
  7 in total

1.  A study on the biological reference interval of urinary alpha 1-microglobulin in a group of Chinese people.

Authors:  Qian Zhang; Xu Jiang; Xiao-Fan Cui; Rui Liu
Journal:  J Clin Lab Anal       Date:  2017-08-03       Impact factor: 2.352

2.  Predictive significance of joint plasma fibrinogen and urinary alpha-1 microglobulin-creatinine ratio in patients with diabetic kidney disease.

Authors:  Lianlian Pan; Mingyi Wo; Chan Xu; Yan Wu; Yali Ye; Fan Han; Xianming Fei; Fengjiao Zhu
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.

Authors:  Agnieszka Żyłka; Paulina Dumnicka; Beata Kuśnierz-Cabala; Agnieszka Gala-Błądzińska; Piotr Ceranowicz; Jakub Kucharz; Anna Ząbek-Adamska; Barbara Maziarz; Ryszard Drożdż; Marek Kuźniewski
Journal:  Mediators Inflamm       Date:  2018-08-09       Impact factor: 4.711

4.  Global diabetic kidney disease research from 2000 to 2017: A bibliometric analysis.

Authors:  Lu-Xi Zou; Ling Sun
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 5.  Current updates on protein as biomarkers for diabetic kidney disease: a systematic review.

Authors:  Rani Sauriasari; Dhonna Dwi Safitri; Nuriza Ulul Azmi
Journal:  Ther Adv Endocrinol Metab       Date:  2021-10-27       Impact factor: 3.565

6.  Prediction of the Short-Term Risk of New-Onset Renal Dysfunction in Patients with Type 2 Diabetes: A Longitudinal Observational Study.

Authors:  Jianbo Xu; Xiaoyun Shan; Yina Xu; Yongjun Ma; Huabin Wang
Journal:  J Immunol Res       Date:  2022-04-20       Impact factor: 4.818

7.  Increased risk markers in women with polycystic ovary syndrome and gestational diabetes mellitus during mid-pregnancy.

Authors:  Liqin Zhang; Lihua Zhang; Zhangwei Wang; Lingling Zhu; Hongxing Wang; Honghui Chen; Haibo Zhang
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.